Synaura is an enterprise with advanced biosynthesis technology established in Pudong District, Shanghai.
We are committed to becoming a first-class enterprise in China's biosynthetic industry, while also being a professional and reliable partner for our clients in the field of nutrition.
Synaura has a vision of over 10 portfolios, covering fields such as biomedicine, agriculture, and healthy food. HMO (Human Milk Oligosaccharides) is the core product of our company in the field of nutrition and health. We hope to bring happiness to millions of Chinese families by providing high-quality HMO raw materials.
Synaura HMO is produced through microbial fermentation technology. HMO has uniform particle size, high purity, and no residual acetic acid odor.
From laboratory research to large-scale production, from local applications to overseas regulatory, Synaura provides customers with full lifecycle solutions.
Leading the domestic market through strong scientific research capabilities and an experienced industrialization team.
Three Global Certifications Lead the Development of HMO Industry
Five Innovation Platforms Support the Future of the Industry
An Integrated Scope from Scientific Research to Production